GT200500198A - Nuevos derivados piperidilo de quinazolina e isoquinazolina - Google Patents
Nuevos derivados piperidilo de quinazolina e isoquinazolinaInfo
- Publication number
- GT200500198A GT200500198A GT200500198A GT200500198A GT200500198A GT 200500198 A GT200500198 A GT 200500198A GT 200500198 A GT200500198 A GT 200500198A GT 200500198 A GT200500198 A GT 200500198A GT 200500198 A GT200500198 A GT 200500198A
- Authority
- GT
- Guatemala
- Prior art keywords
- piperidilo
- derivatives
- new
- isoquinazolina
- quinazolina
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
LA INVENCION SE REFIERE A NUEVOS DERIVADOS DE QUINAZOLINA E ISOQUINAZOLINA SUSTITUIDOS CON PIPERIDILO QUE SIRVEN COMO EFICACES INHIBIDORES DE LA FOSFODIESTERASA (PDE), LA INVENCION TAMBIEN SE REFIERE A COMPUESTOS QUE SON INHIBIDORES SELECTIVOS DE LA PDE10. LA INVENCION ADEMAS SER REFIERE A PRODUCTOS INTERMEDIOS PARA LA PREPARACION DE DICHOS COMPUESTOS Y AL USO DE DICHOS COMPUESTOS EN PROCEDIMIENTOS PARA TRATAR CIERTOS TRASTORNOS DEL SISTEMA NERVIOSO CENTRAL (SNC) U OTROS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59094304P | 2004-07-23 | 2004-07-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200500198A true GT200500198A (es) | 2006-03-02 |
Family
ID=34972555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200500198A GT200500198A (es) | 2004-07-23 | 2005-07-21 | Nuevos derivados piperidilo de quinazolina e isoquinazolina |
Country Status (25)
Country | Link |
---|---|
US (1) | US20060019975A1 (es) |
EP (1) | EP1773805A1 (es) |
JP (1) | JP2008507500A (es) |
CN (1) | CN1989124A (es) |
AP (1) | AP2007003891A0 (es) |
AR (1) | AR050433A1 (es) |
AU (1) | AU2005266080A1 (es) |
BR (1) | BRPI0513475A (es) |
CA (1) | CA2574685A1 (es) |
CR (1) | CR8861A (es) |
EA (1) | EA200700097A1 (es) |
EC (1) | ECSP077193A (es) |
GT (1) | GT200500198A (es) |
IL (1) | IL180205A0 (es) |
MA (1) | MA28746B1 (es) |
MX (1) | MX2007000878A (es) |
NL (1) | NL1029596C2 (es) |
NO (1) | NO20065948L (es) |
PE (1) | PE20060570A1 (es) |
SV (1) | SV2006002175A (es) |
TN (1) | TNSN07021A1 (es) |
TW (1) | TW200616641A (es) |
UY (1) | UY29028A1 (es) |
WO (1) | WO2006011040A1 (es) |
ZA (1) | ZA200700223B (es) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1796669B1 (en) * | 2004-10-01 | 2010-09-22 | Merck Sharp & Dohme Corp. | Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
MX2007010572A (es) * | 2005-03-01 | 2007-10-04 | Wyeth Corp | Compuestos de cinolina y su uso como moduladores de receptor x de higado. |
EP1981868A2 (en) * | 2006-01-27 | 2008-10-22 | Pfizer Products Inc. | Aminophthalazine derivative compounds |
JP2009527562A (ja) * | 2006-02-21 | 2009-07-30 | アムゲン インコーポレイティッド | ホスホジエステラーゼ10阻害剤としてのシンノリン誘導体 |
US20070265256A1 (en) * | 2006-02-21 | 2007-11-15 | Arrington Mark P | Phosphodiesterase 10 inhibitors |
EP1991531A1 (en) * | 2006-02-28 | 2008-11-19 | Amgen Inc. | Cinnoline and quinoxaline derivates as phosphodiesterase 10 inhibitors |
US20090099175A1 (en) * | 2006-03-01 | 2009-04-16 | Arrington Mark P | Phosphodiesterase 10 inhibitors |
US20070265258A1 (en) * | 2006-03-06 | 2007-11-15 | Ruiping Liu | Quinazoline derivatives as phosphodiesterase 10 inhibitors |
AU2007223801A1 (en) * | 2006-03-08 | 2007-09-13 | Amgen Inc. | Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors |
US8173806B2 (en) * | 2006-03-17 | 2012-05-08 | Mitsubishi Gas Chemical Company, Inc. | Method for production of quinazolin-4-one derivative |
CN101495476A (zh) * | 2006-07-10 | 2009-07-29 | H.隆德贝克有限公司 | 6,7-二烷氧基喹唑啉、6,7-二烷氧基酞嗪和6,7-二烷氧基异喹啉的(3-芳基-哌嗪-1-基)、(2-芳基-吗啉-4-基)和(2-芳基-硫代吗啉-4-基)衍生物 |
EP1903038A1 (de) * | 2006-09-07 | 2008-03-26 | Bayer Schering Pharma Aktiengesellschaft | N-(1-Hetaryl-piperidin-4-yl)-(het)arylamide als EP2-Rezeptor Modulatoren |
EP1903037A1 (de) * | 2006-09-07 | 2008-03-26 | Bayer Schering Pharma Aktiengesellschaft | 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors |
US20090062291A1 (en) * | 2007-08-22 | 2009-03-05 | Essa Hu | Phosphodiesterase 10 inhibitors |
US7858620B2 (en) * | 2007-09-19 | 2010-12-28 | H. Lundbeck A/S | Cyanoisoquinoline |
TW200918519A (en) * | 2007-09-19 | 2009-05-01 | Lundbeck & Co As H | Cyanoisoquinoline |
UA102693C2 (ru) | 2008-06-20 | 2013-08-12 | Х. Луннбек А/С | Производные фенилимидазола как ингибиторы фермента pde10a |
CA2746307C (en) | 2008-12-17 | 2013-11-19 | Amgen Inc. | Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors |
TW201200516A (en) | 2009-12-17 | 2012-01-01 | Lundbeck & Co As H | Phenylimidazole derivatives comprising an ethynylene linker as PDE10A enzyme inhibitors |
TWI487705B (zh) | 2009-12-17 | 2015-06-11 | Lundbeck & Co As H | 作為pde10a酵素抑制劑之雜芳香族芳基三唑衍生物 |
TWI481607B (zh) | 2009-12-17 | 2015-04-21 | Lundbeck & Co As H | 作為pde10a酵素抑制劑的2-芳基咪唑衍生物 |
TWI485151B (zh) | 2009-12-17 | 2015-05-21 | Lundbeck & Co As H | 作為pde10a酵素抑制劑之雜芳香族苯基咪唑衍生物 |
MX2012013127A (es) | 2010-05-13 | 2012-11-30 | Amgen Inc | Compuestos heteroariloxiheterociclilo como inhibidores pde10. |
BR112012029026A2 (pt) | 2010-05-13 | 2016-08-02 | Amgen Inc | composto heretocíclicos de nitrogênio úteis como inbidores pde10 |
WO2011143366A1 (en) | 2010-05-13 | 2011-11-17 | Amgen Inc. | Heteroaryloxycarbocyclyl compounds as pde10 inhibitors |
US8946230B2 (en) | 2010-05-13 | 2015-02-03 | Amgen Inc. | Aryl- and heteroaryl- nitrogen-heterocyclic compounds as PDE10 inhibitors |
TW201215607A (en) | 2010-07-02 | 2012-04-16 | Lundbeck & Co As H | Aryl-and heteroarylamid derivatives as PDE10A enzyme inhibitor |
TW201206935A (en) | 2010-07-16 | 2012-02-16 | Lundbeck & Co As H | Triazolo-and pyrazoloquinazoline derivatives as PDE10A enzyme inhibitor |
DE102010042833B4 (de) | 2010-10-22 | 2018-11-08 | Helmholtz-Zentrum Dresden - Rossendorf E.V. | Neue Halogenalkoxychinazoline, deren Herstellung und Verwendung |
JO3089B1 (ar) | 2010-11-19 | 2017-03-15 | H Lundbeck As | مشتقات ايميدازول كمثبطات لانزيمات pde10a |
BR112013021180A2 (pt) | 2011-02-18 | 2019-09-24 | Allergan Inc | derivados de 6,7-dialcóxi-3-isoquinolinol substituído como inibidores de fosfodiesterase 10 (pde10a) |
WO2013045607A1 (en) | 2011-09-30 | 2013-04-04 | H. Lundbeck A/S | Quinazoline linked heteroaromatic tricycle derivatives as pde10a enzyme inhibitors |
WO2013050527A1 (en) | 2011-10-05 | 2013-04-11 | H. Lundbeck A/S | Quinazoline derivatives as pde10a enzyme inhibitors |
AR089361A1 (es) | 2011-12-21 | 2014-08-20 | Lundbeck & Co As H | Derivados de quinolina como inhibidores de la enzima pde10a |
WO2013127817A1 (en) | 2012-02-27 | 2013-09-06 | H. Lundbeck A/S | Imidazole derivatives as pde10a enzyme inhibitors |
TW201348231A (zh) | 2012-02-29 | 2013-12-01 | Amgen Inc | 雜雙環化合物 |
CN104334544B (zh) | 2012-06-04 | 2016-10-19 | 埃科特莱茵药品有限公司 | 苯并咪唑脯氨酸衍生物 |
EA201500399A1 (ru) | 2012-10-10 | 2015-09-30 | Актелион Фармасьютиклз Лтд. | Антагонисты рецептора орексина, которые представляют собой производные [орто-би-(гетеро)арил]-[2-(мета-би-(гетеро)арил)пирролидин-1-ил]метанона |
WO2014071044A1 (en) | 2012-11-01 | 2014-05-08 | Allergan, Inc. | Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a) |
CA2902135A1 (en) | 2013-03-12 | 2014-09-18 | Actelion Pharmaceuticals Ltd | Azetidine amide derivatives as orexin receptor antagonists |
UA116053C2 (uk) | 2013-12-04 | 2018-01-25 | Ідорсія Фармасьютікалз Лтд | Застосування похідних бензоімідазолу-проліну |
US9200016B2 (en) | 2013-12-05 | 2015-12-01 | Allergan, Inc. | Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) |
ES2776359T3 (es) * | 2014-04-04 | 2020-07-30 | H Lundbeck As | Quinazolin-thf-aminas halogenadas como inhibidores de PDE1 |
CN106632089B (zh) * | 2016-11-04 | 2019-06-18 | 中山大学 | 一类喹唑啉类化合物及其制备方法与应用 |
JOP20220131A1 (ar) | 2019-11-28 | 2023-01-30 | Bayer Ag | مركبات أمينو كينولون تحمل بدائل تستخدم كمثبطات لـ dgkalpha من أجل تنشيط المناعة |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3517005A (en) * | 1967-10-26 | 1970-06-23 | Pfizer & Co C | Certain 2- and 4-substituted quinazolines |
GB1460389A (en) * | 1974-07-25 | 1977-01-06 | Pfizer Ltd | 4-substituted quinazoline cardiac stimulants |
IN148482B (es) * | 1977-06-03 | 1981-03-07 | Pfizer | |
JPS60120872A (ja) * | 1983-12-01 | 1985-06-28 | Kyowa Hakko Kogyo Co Ltd | 新規なヘテロ環状化合物及び強心剤 |
US5721237A (en) * | 1991-05-10 | 1998-02-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
CA2118117A1 (en) * | 1993-02-18 | 1994-08-19 | Shigeki Fujiwara | Adenosine uptake inhibitor |
EP0669324A4 (en) * | 1993-09-10 | 1996-04-03 | Eisai Co Ltd | CHINAZOLIN DERIVATIVES. |
JP3919272B2 (ja) * | 1996-12-18 | 2007-05-23 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | キナゾリン系化合物 |
US20030032579A1 (en) * | 2001-04-20 | 2003-02-13 | Pfizer Inc. | Therapeutic use of selective PDE10 inhibitors |
US7074801B1 (en) * | 2001-04-26 | 2006-07-11 | Eisai Co., Ltd. | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
BR0312752A (pt) * | 2002-07-10 | 2005-04-26 | Applied Research Systems | Derivados de benzeno fundido de azolidinona-vinil |
-
2005
- 2005-07-08 US US11/178,104 patent/US20060019975A1/en not_active Abandoned
- 2005-07-11 CA CA002574685A patent/CA2574685A1/en not_active Abandoned
- 2005-07-11 WO PCT/IB2005/002177 patent/WO2006011040A1/en active Application Filing
- 2005-07-11 EA EA200700097A patent/EA200700097A1/ru unknown
- 2005-07-11 AU AU2005266080A patent/AU2005266080A1/en not_active Abandoned
- 2005-07-11 BR BRPI0513475-7A patent/BRPI0513475A/pt not_active Application Discontinuation
- 2005-07-11 AP AP2007003891A patent/AP2007003891A0/xx unknown
- 2005-07-11 MX MX2007000878A patent/MX2007000878A/es unknown
- 2005-07-11 JP JP2007522057A patent/JP2008507500A/ja not_active Withdrawn
- 2005-07-11 EP EP05759014A patent/EP1773805A1/en not_active Withdrawn
- 2005-07-11 CN CNA2005800248487A patent/CN1989124A/zh active Pending
- 2005-07-20 PE PE2005000840A patent/PE20060570A1/es not_active Application Discontinuation
- 2005-07-21 GT GT200500198A patent/GT200500198A/es unknown
- 2005-07-21 UY UY29028A patent/UY29028A1/es not_active Application Discontinuation
- 2005-07-21 AR ARP050103018A patent/AR050433A1/es unknown
- 2005-07-22 TW TW094124808A patent/TW200616641A/zh unknown
- 2005-07-22 SV SV2005002175A patent/SV2006002175A/es not_active Application Discontinuation
- 2005-07-22 NL NL1029596A patent/NL1029596C2/nl not_active IP Right Cessation
-
2006
- 2006-12-20 IL IL180205A patent/IL180205A0/en unknown
- 2006-12-21 NO NO20065948A patent/NO20065948L/no not_active Application Discontinuation
-
2007
- 2007-01-08 ZA ZA200700223A patent/ZA200700223B/xx unknown
- 2007-01-18 CR CR8861A patent/CR8861A/es not_active Application Discontinuation
- 2007-01-22 TN TNP2007000021A patent/TNSN07021A1/fr unknown
- 2007-01-23 MA MA29625A patent/MA28746B1/fr unknown
- 2007-01-23 EC EC2007007193A patent/ECSP077193A/es unknown
Also Published As
Publication number | Publication date |
---|---|
PE20060570A1 (es) | 2006-07-14 |
AP2007003891A0 (en) | 2007-02-28 |
ECSP077193A (es) | 2007-02-28 |
CN1989124A (zh) | 2007-06-27 |
EP1773805A1 (en) | 2007-04-18 |
SV2006002175A (es) | 2006-02-15 |
BRPI0513475A (pt) | 2008-05-06 |
CA2574685A1 (en) | 2006-02-02 |
NL1029596C2 (nl) | 2006-09-06 |
ZA200700223B (en) | 2008-08-27 |
IL180205A0 (en) | 2007-07-04 |
TNSN07021A1 (fr) | 2008-06-02 |
WO2006011040A1 (en) | 2006-02-02 |
JP2008507500A (ja) | 2008-03-13 |
NO20065948L (no) | 2007-01-23 |
AU2005266080A1 (en) | 2006-02-02 |
TW200616641A (en) | 2006-06-01 |
MX2007000878A (es) | 2007-03-12 |
CR8861A (es) | 2007-03-02 |
US20060019975A1 (en) | 2006-01-26 |
NL1029596A1 (nl) | 2006-01-24 |
EA200700097A1 (ru) | 2007-06-29 |
UY29028A1 (es) | 2006-02-24 |
MA28746B1 (fr) | 2007-07-02 |
AR050433A1 (es) | 2006-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200500198A (es) | Nuevos derivados piperidilo de quinazolina e isoquinazolina | |
PA8624101A1 (es) | Derivados de tetrahidroisoquinolinilo de quinazolina e isoquinolina | |
CU23780B7 (es) | Compuestos de quinolina heteroaromaticos y su uso como inhibidores de pde10 | |
CR9135A (es) | Derivados novedosos pirrolidilo de compuestos heteroaromaticos | |
UY30080A1 (es) | Compuestos de heteroarilo biciclicos como inhibidores de pde10 | |
ECSP099378A (es) | Compuestos y composiciones como inhibidores de la proteina quinasa | |
CL2009001212A1 (es) | Compuestos derivados de pirrolo[2,3-d]pirimidina, inhibidores de cinasas; composicion farmaceutica que los comprende; y su uso en el tratamiento de demencia vascular, trastorno del snc, cancer, entre otras. | |
DK1896421T3 (da) | Benzocyclohetapyridiner som hæmmere af receptoren tyrosinkinase MET | |
MX2009011951A (es) | Compuestos y composiciones como inhibidores de cinasa c-kit y pdgfr. | |
EP2012780A4 (en) | SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES AS POTENTE PARP HEMMER | |
ECSP099051A (es) | Inhibidores de tirosina quinasa | |
CL2011000489A1 (es) | Compuestos derivados de pirimido[5,4-d]pirimidina, los cuales actuan como inhibidores de tirosina-quinasas; y composiciones farmaceuticas que los comprenden, utiles en el tratamiento de enfermedades que se caracterizan por una proliferacion celular excesiva o anomala | |
GT201200180A (es) | Derivados de 2-arimidazol heteroaromáticos como inhibidores de enzima pde10a | |
ECSP11011172A (es) | Derivados de tieno [3,2-c]piridina como inhibidores de quinasas para el uso en el tratamiento del cáncer. | |
DK1377586T3 (da) | Tricykliske diazepiner som tocolytiske oxytocinreceptorantagonister | |
MX2009006170A (es) | Compuestos y composiciones como inhibidores de cinasa. | |
GT200500332A (es) | Azabenzoxazoles para el tratamiento de trastornos del snc | |
CR9579A (es) | Inhibidores de tirosina quinasa | |
MX2010001813A (es) | Metodos y composiciones para el tratamiento de canceres. | |
WO2011006794A8 (en) | 3-oxo-2, 3-dihydro-1h-isoindole-4-carboxamides as parp inhibitors | |
CL2011002792A1 (es) | Compuestos derivados de metoxifenil furan-3-(2h)-ona, inhibidores de fosfodiesterasa 10 (pde10); composicion farmaceutica que comprende a uno de los compuestos; y uso de la composicion farmaceutica en la preparacion de medicamentos para tratar trastornos de la alimentacion, obesidad, juego compulsivo, narcolepsia, entre otros. | |
MX2014006015A (es) | Derivados de 3-fenil-isoquinolin-1 (2h) -ona como inhibidores de parp-1. | |
PA8653001A1 (es) | Azanbenzoxazoles para el tratamiento de los trastornos del snc | |
DOP2005000139A (es) | Nuevos derivados piperidilo do quinazolina e isoquinolina | |
DOP2006000004A (es) | Compuestos de quinolina heteroaromaticos. |